Skip to content
drillr.ai
Sign up

688336.SH

三生国健

SSE · Healthcare · Biotechnology · CN

CNY 43.45
−8.81%
Ask drillr

  • Jul 30, 2026, 13:21 UTC

    Controlling shareholder Zhang Yushuai purchased 1.4514 million H-shares of Dongyangguang Pharmaceutical in the open market from July 24 to 30, 2026, for a total consideration of about 56 million yuan.

    Source:

  • Jul 28, 2026, 11:43 UTC

    Sunshine Nuohe's wholly-owned subsidiary Nuohe Shengtai received a Drug Clinical Trial Approval Notice from the National Medical Products Administration for its STC009 injection.

    Source: